MedPath

Association between sleep apnea syndrome and hypertension/endocrine disorders

Not Applicable
Recruiting
Conditions
sleep apnea syndrome, hypertension, metabolic syndrome
Registration Number
JPRN-UMIN000009301
Lead Sponsor
Keio university school of medicine
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
100
Inclusion Criteria

Not provided

Exclusion Criteria

patients with renal dysfunction (Cr>or=3.0)

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
blood pressure after therapy for sleep apnea syndrome (nCPAP)
Secondary Outcome Measures
NameTimeMethod
Parameters for sleep disorders including AHI, parameters for metabolic disorders including BMI, plasma glucose, and continuous glucose monitoring, parameters for endocrine disorders including plasma/urinary aldosterone and catecholamines etc.
© Copyright 2025. All Rights Reserved by MedPath